It’s easy to envision the roles implantable sensors could perform. But is it too hard to overcome the risks?
News & Features
There are six companies with AI-based innovations that everyone in medtech should be watching and talking about.
After favorable feasibility study results, Medtronic is beginning a pilot study of the Extravascular Implantable Cardioverter Defibrillator system.
The Freedom Guardian is a medical alert system smartwatch that device includes two-way voice communication, GPS and Wi-Fi location tracking, text-to-speech messaging, calendar alerts and reminders, and localized weather forecast.
As 3D printing evolves, researchers have gone beyond mere fabrication processes to developing techniques for optimizing how particular materials can be printed. To that end, researchers at Carnegie Mellon University’s College of Engineering have developed a new approach to optimizing the 3D...
Doctors from AmCad BioMed Corp have developed a new screening and imaging tool specifically designed to improve the early detection of thyroid cancer with advanced ultrasound technology.
Boston Scientific is buying Veniti, a firm that has developed a stent system for treating venous obstructive disease, in a deal worth up to $160 million.
Boston Scientific has had a tough time catching up to peers in the transcatheter aortic valve replacement (TAVR) market, but the company's latest news about the Lotus valve has been well received by investors.
The Englewood, CO-based company is pushing for an indication that will have its RF-based technology treating vaginal laxity that could occur following childbirth. The company is also pursuing an indication for stress urinary incontinence.
Antares Pharma has agreed to help Pfizer develop a combination drug-device rescue pen using Antares' QuickShot device.